primary antibodies against cd163 Search Results


primary antibodies against cd163  (MyBiosource Biotechnology)
90
MyBiosource Biotechnology primary antibodies against cd163
(A) Release profile of Dex from microparticles in PBS (n=5). (B) Dex content in the cell culture media (n=3 in blank group and n=6 in treatment groups) following Dex microparticle administration to cells. Media was changed on days 3, 5, and 7. (C-J) Representative images of cells stained for <t>CD163</t> and CCR7 or stained for MerTk and CCR2. (K-N) Image quantification of staining for the surface receptors CD163, CCR7, MerTk, and CCR2 (n=4). Data represent mean ± SEM for all graphs. Statistical analyses were completed by applying one-way ANOVA with Tukey’s post hoc test. *denotes p<0.05 and ** denotes p<0.01. Scale bar = 50 µm.
Primary Antibodies Against Cd163, supplied by MyBiosource Biotechnology, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/primary+antibodies+against+cd163/primary+antibodies+against+cd163/bio_rxiv__674598-139-16-18
Average 90 stars, based on 1 article reviews
primary antibodies against cd163 - by Bioz Stars, 2026-09
90/100 stars
  Buy from Supplier

Image Search Results


(A) Release profile of Dex from microparticles in PBS (n=5). (B) Dex content in the cell culture media (n=3 in blank group and n=6 in treatment groups) following Dex microparticle administration to cells. Media was changed on days 3, 5, and 7. (C-J) Representative images of cells stained for CD163 and CCR7 or stained for MerTk and CCR2. (K-N) Image quantification of staining for the surface receptors CD163, CCR7, MerTk, and CCR2 (n=4). Data represent mean ± SEM for all graphs. Statistical analyses were completed by applying one-way ANOVA with Tukey’s post hoc test. *denotes p<0.05 and ** denotes p<0.01. Scale bar = 50 µm.

Journal: bioRxiv

Article Title: Non-Genetic Reprogramming of Monocytes via Microparticle Phagocytosis for Sustained Modulation of Macrophage Phenotype

doi: 10.1101/674598

Figure Lengend Snippet: (A) Release profile of Dex from microparticles in PBS (n=5). (B) Dex content in the cell culture media (n=3 in blank group and n=6 in treatment groups) following Dex microparticle administration to cells. Media was changed on days 3, 5, and 7. (C-J) Representative images of cells stained for CD163 and CCR7 or stained for MerTk and CCR2. (K-N) Image quantification of staining for the surface receptors CD163, CCR7, MerTk, and CCR2 (n=4). Data represent mean ± SEM for all graphs. Statistical analyses were completed by applying one-way ANOVA with Tukey’s post hoc test. *denotes p<0.05 and ** denotes p<0.01. Scale bar = 50 µm.

Article Snippet: Blocked cells were then incubated overnight at 4°C with primary antibodies against BuGR2 (Invitrogen, cat. #MA1-510), CD163 (1:50; MyBioSource, cat. # MBS302638), CCR7 (1:100; OriGene, cat. # TA320232), MerTk (1:200; abcam, cat. # ab216564), and/or CCR2 (1:200; abcam, cat. # ab176390).

Techniques: Cell Culture, Staining